Reprograming of transcriptional profile of colonic organoids from patients with high blood pressure by minocycline

AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE(2023)

Cited 0|Views15
No score
Abstract
Minocycline, an anti-inflammatory antibiotic drug, rebalances impaired gut microbiota, attenuates neuroinflammation and lowers high blood pressure in animal models of hypertension and in hypertensive patients. Our objective in this study was to investigate if antihypertensive effects of minocycline involve the expression of gut epithelial genes relevant to blood pressure homeostasis using human colonic 3-dimensional organoid culture and high-throughput RNA sequencing. The data demonstrates that minocycline could restore impaired expression of functional genes linked to viral and bacterial immunity, inflammation, protein trafficking and autophagy in human hypertensive organoids.
More
Translated text
Key words
Hypertension,Minocycline,Colonic organoid,Transcriptome,Drug-gene interaction
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined